High Purity FOXO4-DRI: An Advanced Anti-Aging Peptide for Cellular Rejuvenation

Unlock the potential of cellular health with our cutting-edge FOXO4-DRI peptide for enhanced anti-aging effects.

Get a Quote & Sample

Key Product Advantages

Exceptional Purity

Achieve reliable and reproducible results with our FOXO4-DRI peptide, boasting a purity level of over 99%, vital for advanced research in anti-aging beauty peptides.

Targeted Cellular Action

Our FOXO4-DRI peptide precisely targets the FOXO4 and p53 interaction, a novel approach to combat cellular aging and promote longevity.

Certified Quality Assurance

Rest assured with our commitment to quality, with certifications including GMP, HSE, ISO 9001, and USP, ensuring the highest standards for pharmaceutical intermediates.

Key Applications

Anti-Aging Research

Explore the potential of FOXO4-DRI as a key component in developing next-generation anti-aging beauty peptides, understanding mechanisms to induce apoptosis in aging cells.

Cellular Rejuvenation

Investigate how blocking the FOXO4 and p53 interaction with FOXO4-DRI can lead to significant cellular rejuvenation and improved tissue health.

Biotechnology Innovations

Utilize FOXO4-DRI as a high-purity pharmaceutical intermediate to drive innovation in biotechnology, particularly in cell-penetrating peptide therapies.

Customized Peptide Solutions

Benefit from customized peptide synthesis services, allowing researchers to obtain FOXO4-DRI in specific quantities and formulations for unique research projects.

Why Choose Us?

Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.

Global Experience

With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.

Advanced Facilities

Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.

Seamless Scalability

We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).